BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12962332)

  • 1. Cost-effectiveness of alternative approaches in the management of dyspepsia.
    Makris N; Barkun A; Crott R; Fallone CA
    Int J Technol Assess Health Care; 2003; 19(3):446-64. PubMed ID: 12962332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of routine endoscopic biopsies for Helicobacter pylori detection in patients with non-ulcer dyspepsia.
    Makris N; Crott R; Fallone CA; Bardou M; Barkun A
    Gastrointest Endosc; 2003 Jul; 58(1):14-22. PubMed ID: 12838214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Test and treat strategies for Helicobacter pylori in uninvestigated dyspepsia: a Canadian economic analysis.
    Marshall JK; Armstrong D; O'Brien BJ
    Can J Gastroenterol; 2000 May; 14(5):379-88. PubMed ID: 10851277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the dyspeptic patient: a cost-utility study.
    Ebell MH; Warbasse L; Brenner C
    J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness modelling of use of urea breath test for the management of
    Pritchard DM; Bornschein J; Beales I; Beresniak A; Salhi H; Malfertheiner P
    BMJ Open Gastroenterol; 2021 Jul; 8(1):. PubMed ID: 34244244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori "Test-and-Treat" strategy with urea breath test: A cost-effective strategy for the management of dyspepsia and the prevention of ulcer and gastric cancer in Spain-Results of the Hp-Breath initiative.
    Beresniak A; Malfertheiner P; Franceschi F; Liebaert F; Salhi H; Gisbert JP
    Helicobacter; 2020 Aug; 25(4):e12693. PubMed ID: 32285569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis.
    Ladabaum U; Chey WD; Scheiman JM; Fendrick AM
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1491-501. PubMed ID: 12182749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences.
    Ofman JJ; Etchason J; Fullerton S; Kahn KL; Soll AH
    Ann Intern Med; 1997 Feb; 126(4):280-91. PubMed ID: 9036800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of empirical antisecretory therapy versus Helicobacter pylori test for management of dyspepsia: a randomized trial in primary care.
    Jarbol DE; Bech M; Kragstrup J; Havelund T; Schaffalitzky de Muckadell OB
    Int J Technol Assess Health Care; 2006; 22(3):362-71. PubMed ID: 16984065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up of Helicobacter pylori status by using 13C-urea breath test in nonulcer dyspeptic patients after eradication therapy.
    Peng NJ; Hsu PI; Lee SC; Tseng HH; Huang WK; Tsay DG; Lo GH; Lin CK; Cheng JS; Lai KH
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jun; 64(6):337-42. PubMed ID: 11534801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nurse-led dyspepsia clinic using the urea breath test for Helicobacter pylori.
    Fraser A; Williamson S; Lane M; Hollis B
    N Z Med J; 2003 Jun; 116(1176):U479. PubMed ID: 12835807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial: a randomized trial of early endoscopy, Helicobacter pylori testing and empirical therapy for the management of dyspepsia in primary care.
    Duggan AE; Elliott CA; Miller P; Hawkey CJ; Logan RF
    Aliment Pharmacol Ther; 2009 Jan; 29(1):55-68. PubMed ID: 18801056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age.
    Briggs AH; Sculpher MJ; Logan RP; Aldous J; Ramsay ME; Baron JH
    BMJ; 1996 May; 312(7042):1321-5. PubMed ID: 8646042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial management strategies for dyspepsia.
    Delaney BC; Moayyedi P; Forman D
    Cochrane Database Syst Rev; 2003; (2):CD001961. PubMed ID: 12804417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and cost-effectiveness of the 13C-urea breath test as the primary diagnostic investigation for the detection of Helicobacter pylori infection compared to invasive and non-invasive diagnostic tests.
    Nocon M; Kuhlmann A; Leodolter A; Roll S; Vauth C; Willich SN; Greiner W
    GMS Health Technol Assess; 2009 Oct; 5():Doc14. PubMed ID: 21289901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 15-minute [13C]-urea breath test for the diagnosis of Helicobacter pylori infection in patients with non-ulcer dyspepsia.
    Peng NJ; Hsu PI; Lee SC; Tseng HH; Huang WK; Tsay DG; Ger LP; Lo GH; Lin CK; Tsai CC; Lai KH
    J Gastroenterol Hepatol; 2000 Mar; 15(3):284-9. PubMed ID: 10764029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of screening and treating Helicobacter pylori in the management of dyspepsia.
    Moayyedi P; Zilles A; Clough M; Hemingbrough E; Chalmers DM; Axon AT
    Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1245-50. PubMed ID: 10563534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial management strategies for dyspepsia.
    Delaney B; Ford AC; Forman D; Moayyedi P; Qume M
    Cochrane Database Syst Rev; 2005 Oct; (4):CD001961. PubMed ID: 16235292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs of managing Helicobacter pylori-infected ulcer patients after initial therapy.
    Griffiths RI; Rabeneck L; Guzman G; Cromwell DM; Strauss MJ; Robinson JW; Winston B; Li T; Graham DY
    Helicobacter; 2001 Mar; 6(1):66-76. PubMed ID: 11328368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of a 'score and scope' strategy for the management of dyspepsia.
    García-Altés A; Rota R; Barenys M; Abad A; Moreno V; Pons JM; Piqué JM
    Eur J Gastroenterol Hepatol; 2005 Jul; 17(7):709-19. PubMed ID: 15947547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.